Clinical Trials Browser

Phase 2 × Has announcements × Carcinoma, Merkel Cell × Clear all

NCT03599713 2025-08-05

A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201)

Phase 2 Completed

107 enrolled 16 charts 1 FDA

Carcinoma, Merkel Cell

NCT02267603 2023-07-05

Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer

Phase 2 Completed

50 enrolled 11 charts 1 FDA

Carcinoma, Merkel Cell